Clinical trial
The Efficacy and Safety of Desloratadine With Levocetirizine in Treatment of…
NCT00346606 · Lotus Pharmaceutical, Industry · Unknown status
Key facts
| NCT number | NCT00346606 |
|---|---|
| Title | The Efficacy and Safety of Desloratadine With Levocetirizine in Treatment of Chronic Idiopathic Urticaria |
| Official title | A Randomized, Double-Blind, Active-Controlled, Parallel-Group Study to Compare the Efficacy and Safety of Desloratadine 5mg (Denosin®) With Levocetirizine 5mg (Xyzal®) in the Treatment of Chronic Idiopathic Urticaria Patients |
| Lead sponsor | Lotus Pharmaceutical, Industry |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Chronic Idiopathic Urticaria, Urticaria |
| Intervention type | Drug |
| Interventions | Denosin® and Xyzal® |
| Enrollment | 60 |
| Start date | Jan 1, 2006 |
| First posted | Jun 30, 2006 |
| Last update posted | Jun 30, 2006 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: